Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech ...

By Steve Holland, Michael Erman and Patrick WingroveWASHINGTON (Reuters) - U.S. President Donald Trump signed a ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry ... Many of the pharmaceutical company ...

President Trump on Monday called on drugmakers to lower their prices within the next month to be closer to those charged in ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

Learn more about whether ACADIA Pharmaceuticals Inc. or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed ... 3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2025 2.3.4. Co-promotion ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering.

In an era of rapid digital transformation, the pharmaceutical industry is increasingly leveraging advanced integration technologies to streamline operations and enhance efficiency. Rishi Nareshbhai ...